Evidence map›Paper›PMID 22001224›Full record

ArticleArchives of biochemistry and biophysics2011

Structure and catalysis by carbonic anhydrase II: role of active-site tryptophan 5.

Rose Mikulski, John F Domsic, George Ling, Chingkuang Tu, Arthur H Robbins, David N Silverman, Robert McKenna

Abstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rose MikulskiDepartment of Pharmacology and Therapeutics, University of Florida, Gainesville, United States.
John F Domsic
George Ling
Chingkuang Tu
Arthur H Robbins
David N Silverman
Robert McKenna
University of Florida · US

Funding

CATALYTIC MECHANISM OF CARBONIC ANHYDRASER01GM025154 · NIGMS · UNIVERSITY OF FLORIDA · PI SILVERMAN, DAVID N · 1985 to 2012
$4.5M
NIGMS NIH HHS GM 25154NIGMS NIH HHS R01 GM025154
6 · The paper itself

Abstract

The tryptophan residue Trp5, highly conserved in the α class of carbonic anhydrases including human carbonic anhydrase II (HCA II), is positioned at the entrance of the active site cavity and forms a π-stacking interaction with the imidazole ring of the proton shuttle His64 in its outward orientation. We have observed that replacement of Trp5 in HCA II caused significant structural changes, as determined by X-ray diffraction, in the conformation of 11 residues at the N-terminus and in the orientation of the proton shuttle residue His64. Most significantly, two variants W5H and W5E HCA II had His64 predominantly outward in orientation, while W5F and wild type showed the superposition of both outward and inward orientations in crystal structures. Although Trp5 influences the orientation of the proton shuttle His64, this orientation had no significant effect on the rate constant for proton transfer near 1μs(-1), determined by exchange of (18)O between CO(2) and water measured by mass spectrometry. The apparent values of the pK(a) of the zinc-bound water and the proton shuttle residue suggest that different active-site conformations influence the two stages of catalysis, the proton transfer stage and the interconversion of CO(2) and bicarbonate.

Indexed as

Carbonic Anhydrase IICatalysisCatalytic DomainCrystallography, X-RayHistidineHumansHydrogen-Ion ConcentrationKineticsModels, MolecularMutagenesis, Site-DirectedRecombinant ProteinsTryptophanCarbonic Anhydrase IIHistidineRecombinant ProteinsTryptophan

Identifiers

PMID22001224
PMCPMC3223279
OpenAlexW2014140348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.